Skip to main content
Caplight Logo









Okava Pharmaceuticals

Okava Pharmaceuticals

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://okava.com

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Okava Pharmaceuticals operates in Healthcare & Life Sciences and is based in San Francisco, California. It was founded in 2015.

Okava Pharmaceuticals is a biotechnology company that develops pet-specific therapeutics and drug-delivery systems to extend the healthy lifespan of dogs and cats.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Okava Pharmaceuticals Comparables

Compare Okava Pharmaceuticals with similar companies based on industry and business-model similarity.

Okava Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anivive Lifesciences
83%
Vetbiolix
82%
Familiar Therapeutics
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Okava Pharmaceuticals Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Okava Pharmaceuticals. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Michael Klotsman

Founder & CEO

Founding Team

For institutional investors. Book with your work email.

Okava Pharmaceuticals Investors

Notable investors and investment history

Okava Pharmaceuticals investors
InvestorRounds
Propel(x)Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 103% MoM, reaching 2.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Okava Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Okava Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Okava Pharmaceuticals's valuation, stock price, and market status.

Is Okava Pharmaceuticals a public or private company?

Okava Pharmaceuticals is a private company.

What is the current stock price of Okava Pharmaceuticals?

Okava Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Okava Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Okava Pharmaceuticals worth (valuation)?

Valuation information for Okava Pharmaceuticals is not publicly available.

Can I buy Okava Pharmaceuticals stock?

Okava Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Okava Pharmaceuticals's last funding round?

Funding round information for Okava Pharmaceuticals is not publicly available.

Who are the main investors in Okava Pharmaceuticals?

Key investors in Okava Pharmaceuticals include Propel(x).

Will Okava Pharmaceuticals IPO soon?

No public IPO plans have been announced for Okava Pharmaceuticals.

How can I track Okava Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades in Okava Pharmaceuticals's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range4
Year Founded2015
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?